These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21342530)

  • 1. A pseudotype baculovirus expressing the capsid protein of foot-and-mouth disease virus and a T-cell immunogen shows enhanced immunogenicity in mice.
    Cao Y; Lu Z; Sun P; Fu Y; Tian F; Hao X; Bao H; Liu X; Liu Z
    Virol J; 2011 Feb; 8():77. PubMed ID: 21342530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice.
    Fan H; Pan Y; Fang L; Wang D; Wang S; Jiang Y; Chen H; Xiao S
    J Virol Methods; 2008 Jun; 150(1-2):21-6. PubMed ID: 18394722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
    Kim A; Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    J Virol; 2022 Jun; 96(12):e0052822. PubMed ID: 35604219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
    Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
    Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity.
    Dong H; Lu Y; Zhang Y; Mu S; Wang N; Du P; Zhi X; Wen X; Wang X; Sun S; Zhang Y; Guo H
    J Virol; 2021 Jul; 95(16):e0017721. PubMed ID: 34011545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist.
    Lei Y; Shao J; Ma F; Lei C; Chang H; Zhang Y
    Mol Immunol; 2020 May; 121():118-126. PubMed ID: 32199211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of immune responses against FMD by a DNA vaccine encoding the FMDV/O/IRN/2007 VP1 gene and the conventional inactivated vaccine in an animal model.
    Sedeh FM; Soleimanjahi H; Jalilian A; Mahravani H
    Virol Sin; 2012 Oct; 27(5):286-91. PubMed ID: 23001482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin.
    Cui B; Liu X; Zhou P; Fang Y; Zhao D; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3367-3379. PubMed ID: 30888465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric Porcine Parvovirus VP2 Virus-like Particles with Epitopes of South African Serotype 2 Foot-and-Mouth Disease Virus Elicits Specific Humoral and Cellular Responses in Mice.
    Li Q; Ma X; Shen Y; Dai J; Nian X; Shang X; Chen J; Wubshet AK; Zhang J; Zheng H
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle.
    Ren J; Yang L; Xu H; Zhang Y; Wan M; Liu G; Zhao L; Wang L; Yu Y
    Vaccine; 2011 Oct; 29(45):7960-5. PubMed ID: 21872635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T
    Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
    Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
    Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
    Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability.
    Xie Y; Li H; Qi X; Ma Y; Yang B; Zhang S; Chang H; Yin X; Li Z
    Vaccine; 2019 Mar; 37(14):2016-2025. PubMed ID: 30808570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.